Caribou Biosciences, Inc. Shares Outstanding (Cover Page)
Caribou Biosciences, Inc. (CRBU) had Shares Outstanding (Cover Page) of 107.21 million shares as of 2026-08-07, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-07: Entity Common Stock, Shares Outstanding 107.21M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 99.18M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 96.64M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 93.47M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 107.21M shares 10-Q · filed 2026-08-13 |
| 2026-04-30 | 99.18M shares 10-Q · filed 2026-05-07 |
| 2026-02-27 | 96.64M shares 10-K · filed 2026-03-05 |
| 2025-11-03 | 93.47M shares 10-Q · filed 2025-11-12 |
| 2025-08-05 | 93.12M shares 10-Q · filed 2025-08-12 |
| 2025-05-02 | 93.00M shares 10-Q · filed 2025-05-08 |
| 2025-03-04 | 93.00M shares 10-K · filed 2025-03-10 |
| 2024-11-01 | 90.55M shares 10-Q · filed 2024-11-06 |
| 2024-08-01 | 90.36M shares 10-Q · filed 2024-08-06 |
| 2024-05-02 | 90.32M shares 10-Q · filed 2024-05-07 |
| 2024-03-05 | 90.31M shares 10-K · filed 2024-03-11 |
| 2023-11-02 | 88.43M shares 10-Q · filed 2023-11-07 |
| 2023-08-03 | 88.28M shares 10-Q/A · filed 2023-11-17 |
| 2023-05-04 | 61.36M shares 10-Q/A · filed 2023-11-17 |
| 2023-03-03 | 61.30M shares 10-K · filed 2023-03-09 |
| 2022-11-03 | 61.00M shares 10-Q · filed 2022-11-08 |
| 2022-08-01 | 60.84M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 60.71M shares 10-Q · filed 2022-05-09 |
| 2022-03-17 | 60.66M shares 10-K · filed 2022-03-21 |
| 2021-11-05 | 60.19M shares 10-Q · filed 2021-11-09 |
| 2021-08-31 | 59.97M shares 10-Q · filed 2021-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |